Clinical trial on the effect of continuous positive pressure (CPAP). Objectives: 1) To assess the total or partial recovery of oxidative and inflammatory damage after recovering IH. 2) To check whether the results obtained in vitro on the recovery of the damage according to the form of manifestation of IH are validated in SAHS patients. 3) To determine if CPAP reduces nighttime blood pressure and arterial stiffness depending on whether or not patients have a non-dipping pattern of blood pressure and depending on the degree of correction of IH. 4) To clarify whether residual nocturnal hypoxemia influences the recovery of oxidative and inflammatory damage in patients. 5) To determine nasal and intestinal microbioma and the effect of CPAP treatment
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from baseline in 8 isoprostane levels
Timeframe: 4 months
Change from baseline in microbiota population diversity from stool samples
Timeframe: 4 months
Change from baseline in microbiota population diversity from nasopharyngeal samples
Timeframe: 4 months
Change from baseline in microbiota population abundance from stool samples
Timeframe: 4 months
Change from baseline in microbiota population abundance from nasopharyngeal samples
Timeframe: 4 months
Change from baseline in microbiota population color maps from stool samples
Timeframe: 4 months
Change from baseline in microbiota color maps from nasopharyngeal samples
Timeframe: 4 months